文献速递前列腺癌

初次活检患者中的磁共振成像靶向活检与前列腺癌过度治疗风险:分级问题

Magnetic resonance imaging targeted biopsy in biopsy-naïve patients and the risk of overtreatment in prostate cancer: a grading issue.
PubMed 文献 · BJU Int · 2023-11-20

研究纳入2016至2022年前列腺影像报告和数据系统评分≥3、初次活检的655例患者,比较2014与2019年国际泌尿病理学会(ISUP)推荐对分级组分布及与根治性前列腺切除术(RP)一致性的影响。2019年推荐与ISUP分级组4减少、分级组2增加相关,并减少RP标本降级、提高与RP标本的一致性。

要点

  • 2019年ISUP推荐较2014年推荐使ISUP分级组4降低(差异范围-13%至-5%)、分级组2升高(差异范围+6%至+11%)。
  • 在行RP的患者中,所有活检策略的降级均显著减少(差异范围-19%至-12%;P≤0.008)。
  • 2019年ISUP推荐与RP标本一致性提高(差异范围+12%至+13%;P≤0.02)相关。

核心结论

  • 使用2019年ISUP推荐可减轻磁共振成像靶向活检引起的分级迁移,并提高与最终RP标本的一致性。

研究设计与样本

  • 从2016至2022年前瞻性维护的数据库中识别出655例初次活检、因前列腺影像报告和数据系统评分≥3病灶行磁共振成像靶向和系统活检的患者。
  • 临床显著前列腺癌检出249例,其中69例行根治性前列腺切除术。
  • 采用Wilcoxon符号秩检验和McNemar检验分别比较应用2014年(即最高分级)和2019年(即整体分级)ISUP推荐后的ISUP分级组分布及与RP的一致性。

主要发现

  • 与2014年ISUP推荐相比,2019年ISUP推荐在仅MRI靶向活检、MRI靶向加病灶周围活检和MRI靶向加系统活检中均与ISUP分级组4显著降低(差异范围-13%至-5%)和ISUP分级组2显著升高(差异范围+6%至+11%)相关(所有P<0.01)。
  • 在行RP的患者中,所有活检策略的降级均显著减少(差异范围-19%至-12%;P≤0.008),同时与RP标本的一致性提高(差异范围+12%至+13%;P≤0.02)。
  • 使用2019年ISUP推荐与RP标本的治疗负担降低相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of applying the 2014 and 2019 International Society of Urological Pathology (ISUP) recommendations on grade group distribution and concordance with radical prostatectomy (RP). MATERIALS AND METHODS: Overall, 655 biopsy-naïve patients diagnosed by magnetic resonance imaging (MRI) targeted and systematic biopsies for Prostate Imaging Reporting and Data System score ≥3 lesions were identified from a prospectively maintained database from 2016 and 2022. Clinically significant prostate cancer was detected in 249 patients, of whom 69 underwent RP. Wilcoxon signed rank and McNemar's tests were used to compare the ISUP grade group distribution and concordance with RP after applying the 2014 (i.e., highest grade) and 2019 (i.e., global grade) ISUP recommendations, respectively. RESULTS: Compared to the 2014 ISUP recommendations, the 2019 ISUP recommendations were associated with a significant decrease in ISUP Grade Group 4 (range of difference from -13% to -5%) and an increase in ISUP Grade Group 2 (range of difference from +6% to +11%) in MRI targeted biopsy only, MRI targeted with perilesional biopsies, and MRI targeted with systematic biopsies (all P < 0.01). In patients who underwent RP, a significant decrease in downgrading was observed with all biopsy strategies (range of difference from -19% to -12%; P ≤ 0.008), along with an increase in concordance with RP specimen (range of difference from +12% to +13%; P ≤ 0.02). The use of the 2019 ISUP recommendation was associated with RP specimen a lower treatment burden. CONCLUSIONS: The use of the 2019 ISUP recommendations mitigates the grade migration induced by MRI targeted biopsy and improves the concordance with the final RP specimen.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Jabbour T, Peltier A, Rocq L, et al. Magnetic resonance imaging targeted biopsy in biopsy-naïve patients and the risk of overtreatment in prostate cancer: a grading issue. BJU Int. 2023. PMID: 37943114. doi:10.1111/bju.16221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。